Igenica Biotherapeutics' Series A Round

Igenica Biotherapeutics raised a round of funding on March 13, 2009.

Igenica is focused on the discovery and development of antibodies and antibody-drug conjugates (ADCs) for the treatment of cancer. Igenica is the only biotherapeutic company that fully powers the ADC …

Articles about Igenica Biotherapeutics' Series A Round: